• Home
  • Pharmaceuticals and Healthcare
Global Irritable Bowel Syndrome (IBS) Market Opportunities and Forecast 2022-2028

Global Irritable Bowel Syndrome (IBS) Market Opportunities and Forecast 2022-2028

Report Code: KNJ1133736 | No. of Pages: 131 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Feb-2022 
This report provides a comprehensive analysis of current global Irritable Bowel Syndrome (IBS) market based on segmented types and downstream applications. Major product development trends are discussed  under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Irritable Bowel Syndrome (IBS) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Irritable Bowel Syndrome (IBS) market is estimated at $ 3560 million in 2021, and projected to grow at a CAGR of 8.7% to $ 6380 million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Irritable Bowel Syndrome (IBS) Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Irritable Bowel Syndrome (IBS) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Irritable Bowel Syndrome (IBS) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Irritable Bowel Syndrome (IBS) industry. 
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. 
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
    IBS-D Drug

    IBS-C Drug


Segmented by Application
    Women

    Men

Segmented by Country
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

Key manufacturers included in this survey
    Sebela Pharmaceuticals Inc

    Bausch Health

    Astellas Pharmaceuticals

    Allergan



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Irritable Bowel Syndrome (IBS) Market Status and Forecast (2017-2028)
        1.3.2 Global Irritable Bowel Syndrome (IBS) Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Irritable Bowel Syndrome (IBS) Supply by Company
    2.1 Global Irritable Bowel Syndrome (IBS) Sales Volume by Company
    2.2 Global Irritable Bowel Syndrome (IBS) Sales Value by Company
    2.3 Global Irritable Bowel Syndrome (IBS) Price by Company
    2.4 Irritable Bowel Syndrome (IBS) Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Irritable Bowel Syndrome (IBS) Market Status by Type
    3.1 Irritable Bowel Syndrome (IBS) Type Introduction
        3.1.1 IBS-D Drug

        3.1.2 IBS-C Drug

        3.1.3 Other
    3.2 Global Irritable Bowel Syndrome (IBS) Market by Type
        3.2.1 Global Irritable Bowel Syndrome (IBS) Sales Volume by Type (2017-2022)
        3.2.2 Global Irritable Bowel Syndrome (IBS) Sales Value by Type (2017-2022)
        3.2.3 Global Irritable Bowel Syndrome (IBS) Price by Type (2017-2022)
    3.3 North America: by Type
    3.4 Europe: by Type
    3.5 Asia Pacific: by Type
    3.6 Central & South America: by Type
    3.7 Middle East & Africa: by Type
4 Global and Regional Irritable Bowel Syndrome (IBS) Market Status by Application
    4.1 Irritable Bowel Syndrome (IBS) Segment by Application
        4.1.1 Women

        4.1.2 Men
    4.2 Global Irritable Bowel Syndrome (IBS) Market by Application
        4.2.1 Global Irritable Bowel Syndrome (IBS) Sales Volume by Application (2017-2022)
        4.2.2 Global Irritable Bowel Syndrome (IBS) Sales Value by Application (2017-2022)
        4.2.3 Global Irritable Bowel Syndrome (IBS) Price by Application (2017-2022)
    4.3 North America: by Application
    4.4 Europe: by Application
    4.5 Asia Pacific: by Application
    4.6 Central & South America: by Application
    4.7 Middle East & Africa: by Application
5 Global Irritable Bowel Syndrome (IBS) Market Status by Region
    5.1 Global Irritable Bowel Syndrome (IBS) Market by Region
        5.1.1 Global Irritable Bowel Syndrome (IBS) Sales Volume by Region
        5.1.2 Global Irritable Bowel Syndrome (IBS) Sales Value by Region
    5.2 North America Irritable Bowel Syndrome (IBS) Market Status
    5.3 Europe Irritable Bowel Syndrome (IBS) Market Status
    5.4 Asia Pacific Irritable Bowel Syndrome (IBS) Market Status
    5.5 Central & South America Irritable Bowel Syndrome (IBS) Market Status
    5.6 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Status
6 North America Irritable Bowel Syndrome (IBS) Market Status
    6.1 North America Irritable Bowel Syndrome (IBS) Market by Country
        6.1.1 North America Irritable Bowel Syndrome (IBS) Sales Volume by Country (2017-2022)
        6.1.2 North America Irritable Bowel Syndrome (IBS) Sales Value by Country (2017-2022)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Irritable Bowel Syndrome (IBS) Market Status
    7.1 Europe Irritable Bowel Syndrome (IBS) Market by Country
        7.1.1 Europe Irritable Bowel Syndrome (IBS) Sales Volume by Country (2017-2022)
        7.1.2 Europe Irritable Bowel Syndrome (IBS) Sales Value by Country (2017-2022)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Irritable Bowel Syndrome (IBS) Market Status
   8.1 Asia Pacific Irritable Bowel Syndrome (IBS) Market by Country
        8.1.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales Volume by Country (2017-2022)
        8.1.2 Asia Pacific Irritable Bowel Syndrome (IBS) Sales Value by Country (2017-2022)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Irritable Bowel Syndrome (IBS) Market Status
    9.1 Central & South America Irritable Bowel Syndrome (IBS) Market by Country
        9.1.1 Central & South America Irritable Bowel Syndrome (IBS) Sales Volume by Country (2017-2022)
        9.1.2 Central & South America Irritable Bowel Syndrome (IBS) Sales Value by Country (2017-2022)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Status
    10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market by Country
        10.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Volume by Country (2017-2022)
        10.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Value by Country (2017-2022)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Irritable Bowel Syndrome (IBS) Manufacturing Cost Analysis
    11.5 Irritable Bowel Syndrome (IBS) Sales Channel and Distributors Analysis
        11.5.1 Irritable Bowel Syndrome (IBS) Sales Channel
        11.5.2 Irritable Bowel Syndrome (IBS) Distributors
    11.6 Irritable Bowel Syndrome (IBS) Downstream Major Buyers
12 Global Irritable Bowel Syndrome (IBS) Market Forecast by Type and by Application
    12.1 Global Irritable Bowel Syndrome (IBS) Sales Volume and Sales Value Forecast (2023-2028)
    12.2 Global Irritable Bowel Syndrome (IBS) Forecast by Type
        12.2.1 Global Irritable Bowel Syndrome (IBS) Sales Volume Forecast by Type
        12.2.2 Global Irritable Bowel Syndrome (IBS) Sales Value Forecast by Type
        12.2.3 Global Irritable Bowel Syndrome (IBS) Price Forecast by Type
    12.3 Global Irritable Bowel Syndrome (IBS) Forecast by Application
        12.3.1 Global Irritable Bowel Syndrome (IBS) Sales Volume Forecast by Application
        12.3.2 Global Irritable Bowel Syndrome (IBS) Sales Value Forecast by Application
        12.3.3 Global Irritable Bowel Syndrome (IBS) Price Forecast by Application
13 Global Irritable Bowel Syndrome (IBS) Market Forecast by Region/Country
    13.1 Global Irritable Bowel Syndrome (IBS) Market Forecast by Region (2023-2028)
        13.1.1 Global Irritable Bowel Syndrome (IBS) Sales Volume Forecast by Region (2023-2028)
        13.1.2 Global Irritable Bowel Syndrome (IBS) Sales Value Forecast by Region (2023-2028)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Takeda

        14.1.1 Company Information
        14.1.2 Irritable Bowel Syndrome (IBS) Product Introduction
        14.1.3 Takeda
 Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.1.4 SWOT Analysis
    14.2 Sucampo Pharmaceuticals (Mallinckrodt)

        14.2.1 Company Information
        14.2.2 Irritable Bowel Syndrome (IBS) Product Introduction
        14.2.3 Sucampo Pharmaceuticals (Mallinckrodt)
 Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.2.4 SWOT Analysis
    14.3 Sebela Pharmaceuticals Inc

        14.3.1 Company Information
        14.3.2 Irritable Bowel Syndrome (IBS) Product Introduction
        14.3.3 Sebela Pharmaceuticals Inc
 Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.3.4 SWOT Analysis
    14.4 Bausch Health

        14.4.1 Company Information
        14.4.2 Irritable Bowel Syndrome (IBS) Product Introduction
        14.4.3 Bausch Health
 Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.4.4 SWOT Analysis
    14.5 Astellas Pharmaceuticals

        14.5.1 Company Information
        14.5.2 Irritable Bowel Syndrome (IBS) Product Introduction
        14.5.3 Astellas Pharmaceuticals
 Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.5.4 SWOT Analysis
    14.6 Allergan

        14.6.1 Company Information
        14.6.2 Irritable Bowel Syndrome (IBS) Product Introduction
        14.6.3 Allergan
 Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
        14.6.4 SWOT Analysis
    ...
15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com